BridgeBio is substantially improved the progress of an innovative treatment for ATTR-CM, utilizing the compound. Early patient results indicates promising improvements for patients affected by this debilitating illness. https://attr-cm438201.blogdun.com/42850088/company-progresses-cardiac-amyloidosis-management-using-attruby